Morgan Stanley’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.74M | Buy |
|
|||||
|
2025
Q1 | $1.83M | Buy |
|
|||||
|
2024
Q4 | $822K | Sell |
|
|||||
|
2024
Q3 | $597K | Buy |
|
|||||
|
2024
Q2 | $190K | Buy |
|
|||||
|
2024
Q1 | $156K | Buy |
|
|||||
|
2023
Q4 | $18.6K | Buy |
|
|||||
|
2023
Q3 | $9.05K | Sell |
|
|||||
|
2023
Q2 | $13.3K | Sell |
|
|||||
|
2023
Q1 | $15.3K | Sell |
|
|||||
|
2022
Q4 | $24.7K | Sell |
|
|||||
|
2022
Q3 | $31K | Sell |
|
|||||
|
2022
Q2 | $259K | Buy |
|
|||||
|
2022
Q1 | $203K | Sell |
|
|||||
|
2021
Q4 | $319K | Sell |
|
|||||
|
2021
Q3 | $626K | Sell |
|
|||||
|
2021
Q2 | $1.46M | Sell |
|
|||||
|
2021
Q1 | $3.4M | Sell |
|
|||||
|
2020
Q4 | $3.47M | Buy |
|
|||||
|
2020
Q3 | $2.56M | Buy |
|
|||||
|
2020
Q2 | $2.14M | Buy |
|
|||||
|
2020
Q1 | $42K | Sell |
|
|||||
|
2019
Q4 | $279K | Buy |
|
|||||
|
2019
Q3 | $84K | Buy |
|
|||||
|
2019
Q2 | $50K | Sell |
|
|||||
|
2019
Q1 | $265K | Sell |
|
|||||
|
2018
Q4 | $300K | Buy |
|
|||||
|
2018
Q3 | $362K | Sell |
|
|||||
|
2018
Q2 | $395K | Sell |
|
|||||
|
2018
Q1 | $484K | Buy |
|
|||||
|
2017
Q4 | $96K | Buy |
|
|||||
|
2017
Q3 | $9K | Buy |
|
|||||
|
2017
Q2 | $6K | Sell |
|
|||||
|
2017
Q1 | $101K | Sell |
|
|||||
|
2016
Q4 | $276K | Buy |
|
|||||
|
2016
Q3 | $16K | Buy |
|
|||||
|
2016
Q2 | $19K | Buy |
|